EGFR and melanoma: Notably, semaphorin-NRP1 signaling is not involved in sustaining cell viability, and we have previously shown that VEGF-NRP1 autocrine signaling is not implicated in the pathway leading to EGFR upregulation and drug resistance in melanoma cells [7].